SVF Endurance (Cayman) Ltd, 10% Owner at Vir Biotechnology, Inc. (VIR), sold 297,270 shares at $29.70 ($8.7M) on 2023-02-02, disclosed to the SEC on 2023-02-03.
Open-market sale of $8.7M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.78 | 26,661 | $767K | 8.8% |
| 2 | $28.78 | 26,661 | $767K | 8.8% |
| 3 | $29.19 | 35,173 | $1.0M | 11.7% |
| 4 | $29.19 | 35,173 | $1.0M | 11.7% |
| 5 | $29.70 | 86,801 | $2.6M | 29.5% |
| 6 | $29.70 | 86,801 |
| $2.6M |
| 29.5% |
| Total | $29.41 avg | 297,270 | $8.7M | 100% |
| Filing → |
| VIR | SELL | 2025-10-30 | $319K | — | Filing → |
| VIR | SELL | 2025-10-22 | $2.7M | — | Filing → |
| VIR | SELL | 2025-10-17 | $359K | — | Filing → |